Skip to main content

Security report for msd.pl

Merck & Co., Inc. · Healthcare · Poland

Medium risk. 11 critical or high findings in GDPR outside view, Email security and 2 other checks.

Security score

54/100

Risk levelMedium

0–100, higher is better. How it is calculated

MSD Polska is the Polish branch of Merck & Co., Inc., a leading multinational pharmaceutical company. The website serves as a corporate portal providing information about MSD's pharmaceutical products, vaccines, clinical research, and social responsibility initiatives in Poland. It targets healthcare professionals, patients, and partner organizations, reflecting a strong market position in the healthcare sector. The site emphasizes transparency, grant programs, and corporate values, aligning with MSD's global brand identity. Technically, the website is built on WordPress with modern plugins such as Yoast SEO and Tiny Slider, and integrates Google Tag Manager for analytics and OneTrust for cookie consent management. The site is mobile-optimized, accessible, and SEO-friendly, demonstrating a mature digital infrastructure. Performance is moderate with good user experience and clear navigation. From a security perspective, the site enforces HTTPS and implements cookie consent mechanisms, but lacks visible security headers and published security policies. No vulnerabilities or exposed sensitive data were detected. The absence of direct contact emails or phone numbers is noted, with contact primarily via a form. WHOIS data is unavailable due to .pl registry privacy norms, but the site’s branding and external links confirm legitimacy. Overall, MSD Polska’s website is professional, secure, and compliant with GDPR, supporting its enterprise-level business operations. Strategic improvements in security policy transparency and incident response communication would enhance trust and compliance further.

Scanned

NIS2 and GDPR posture

GDPR outside view
25/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

11 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics, Facebook, Twitter, LinkedIn, YouTube

      What to do: Document all third-party data sharing in your privacy policy

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

Need hands-on remediation? Email guard@offseq.com

Keep watching msd.pl

This scan found 26 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
42
Security headers
80
Email security
50
DNS health
25
Network security
100
GDPR outside view
25
Average
54

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

MSD Polska operates as an essential entity within the healthcare sector, focusing on pharmaceutical products and vaccines. Its business model revolves around research, development, clinical trials, and distribution of medicines. The company leverages grant programs and social responsibility initiatives to strengthen its market presence and stakeholder engagement. The website reflects a well-established enterprise with a global parent company, Merck & Co., Inc. The partnership ecosystem includes specialized sites for medical professionals, animal health, and CSR reporting. The absence of direct contact details suggests a controlled communication approach typical for large pharmaceutical firms. Growth indicators include active clinical research and public grant programs. The company maintains a consistent brand image and high trust indicators across digital channels.

Security posture

The security posture of MSD Polska’s website is solid with mandatory HTTPS encryption and GDPR-compliant cookie consent. However, the lack of explicit security headers such as Content-Security-Policy and X-Frame-Options represents an area for improvement. No security or incident response policies are published, which could hinder transparency and readiness in case of security events. The site does not expose sensitive data or use vulnerable libraries based on the provided data. The use of Google Tag Manager and OneTrust indicates awareness of privacy and tracking controls. Overall, the security maturity is good but could be enhanced by formalizing security policies and vulnerability disclosure mechanisms.

Recommendations

  1. Publish a comprehensive security policy and incident response plan accessible on the website.
  2. Implement HTTP security headers including Content-Security-Policy, X-Content-Type-Options, and X-Frame-Options.
  3. Establish and publicize a vulnerability disclosure program or security.txt file.
  4. Provide clear Data Protection Officer contact information to improve GDPR transparency.
  5. Regularly audit third-party scripts and tracking tools to minimize privacy risks and improve performance.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Merck & Co., Inc.
Description
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Key services
Pharmaceutical products, Vaccines, Clinical research, Grant programs
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, Tiny Slider, Google Tag Manager, OneTrust Cookie Consent
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data detected

Analytics and tracking

Services
Google Analytics (via Google Tag Manager)
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and maintained using WordPress CMS
  2. Content is focused on pharmaceutical products, clinical research, and corporate responsibility
  3. Strong presence of official MSD branding and social media links
  4. Privacy and cookie policies are present and GDPR compliant
  5. No direct contact emails or phone numbers publicly listed, contact is via form
  6. No visible security headers detected in provided data
  7. No WHOIS data available publicly for domain, typical for .pl domains with privacy protection
  8. No adult or questionable content detected
  9. External links mostly to official MSD and partner domains
Technical notes

Notes

The website is built on a WordPress CMS platform enhanced with Yoast SEO for search optimization and Tiny Slider for interactive content. Google Tag Manager is used for analytics and event tracking, while OneTrust manages cookie consent, indicating compliance with privacy regulations. The site is mobile-optimized and accessible, with good navigation and professional design. Performance is moderate, with potential for improvement through optimization of scripts and caching. The absence of visible security headers suggests technical debt in security hardening. Hosting details are not explicitly available, but the presence of CDN and external domains indicates a distributed infrastructure. Overall, the technical implementation supports a robust and user-friendly digital presence suitable for an enterprise healthcare organization.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with msd.pl. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review msd.pl.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.